UC San Diego Cardiology
@UCSDCardiology
Followers
796
Following
649
Media
148
Statuses
933
Official Twitter account for the Division of Cardiovascular Medicine at UC San Diego School of Medicine
La Jolla, CA
Joined July 2022
Congratulations to the class of 2025!
What an amazing night celebrating the graduating @UCSDCardiology fellows of 2025. We are so proud of you all and are excited to see your careers blossom! 🫀🎓🍾🍻
0
1
11
In our new study, we evaluate the use of CAC scoring in low risk individuals @AJPCardio @ASPCardio 🧵 @UCSDCardiology @UCSDCardFellows @Tall_JonD @AlexRazavi @MichaelJBlaha
https://t.co/brzYlBKDkv
0
0
3
Grateful to join patients, caregivers, friends and providers at the #ACHA walk for 1 for 100 in San Diego! Together, we walk for #awareness, #advocacy, and #support for CHD care and research. ❤️👣 #ACHD @ACHA_Heart @UCSDCardiology @ACHD_SanDiego @laithalsh @matthewcarazo
2
4
7
New publication @PamTaubMD: Time-restricted eating improves quality of life, heart rate, and mitochondrial function in patients with postural orthostatic tachycardia syndrome. An open-label pilot study @UCSDCardFellows @UCSDHealthSci @UCSDHealth
https://t.co/DvhCCBvxwB
nature.com
Scientific Reports - Time-restricted eating improves quality of life, heart rate, and mitochondrial function in patients with postural orthostatic tachycardia syndrome. An open-label pilot study
0
0
4
New publication from @JanetMa_MD Sex Differences in Pulmonary Hypertension and Associated Right Ventricular Dysfunction @UCSDCardFellows @UCSDHealthSci @UCSDHealth
https://t.co/nryy3dX9dF
ajconline.org
Pulmonary hypertension (PH) is a heterogenous disease associated with poor clinical outcomes (1). While clinically PH is classified by World Health Organization groups based on etiology, grouping by...
0
0
0
New publication from Dr. Wettersten: Galectin-3 Is Associated With Risk of Cardiovascular and Kidney Outcomes in Ambulatory Veterans @UCSDCardFellows @UCSDHealthSci @UCSDHealth @loridanielsmd
https://t.co/emsjbwrdw1
kidneymedicinejournal.org
Cardiovascular and kidney disease are highly prevalent comorbid conditions, and each is a risk factor for the other condition. We evaluated whether Galectin-3 (Gal-3), a biomarker of organ fibrosis,...
0
0
1
Welcoming Dr. Nishimura-Kaminski to the general cardiology faculty! @UCSDCardFellows @UCSDHealth @UCSDHealthSci @UCSDMedSchool
0
2
10
Welcoming Dr. Rajaram to the general cardiology faculty! @UCSDCardFellows @UCSDHealth @UCSDHealthSci @UCSDMedSchool
0
2
12
We have just opened an advanced ACHD fellowship position for 2026 at the University of California in San Diego. Please submit applications via ERAS if interested. #ACHD @ACHA_Heart @CincyACHD @ACHD_SanDiego @AHAScience @ACCCardioCareer
1
9
13
💛💙 Meet one of UCSD Cardiology’s rising stars 💛💙 ✨ David Timmer, MD ✨ 📍 Atlanta, GA + Port-au-Prince, Haiti → 🎓 Morehouse SOM → 🩺 @ucsdim IM Chief → 🌴 @UCSDCardiology fellow 💪🏼 💡 Drawn here for the unbeatable clinical experience and stayed on for the amazing
0
1
10
Save the date! Friday, May 15, 2026 for the 20th Annual Biomarkers Symposium. Estancia Resort, La Jolla CA. More to come! @UCSDHealth @IFCC_CCB @UCSDCardFellows @ucsdcardiology @loridanielsmd @ChrisDefilippi
0
5
5
Our recent publication in AJPC @ASPCardio highlights the new paradigm of high-risk primary prevention and current clinical trials examining this patient population. https://t.co/UDrQLleim3 We can no longer dichotomize patients into primary and secondary prevention. In the
4
14
65
💛💙 Meet UCSD Cardiology’s newest heart hero 💛💙 ✨ Alex Wells, MD ✨ 📍 Piedmont, CA → 🎓 Vanderbilt → 🩺 UCSF → 🌴 San Diego☀️ 💡Drawn here for the mentorship & amazing co-fellows 🙌 #IllBeThereForYou 🏃♂️🎾🌊 When not in the CCU, you’ll find him on the courts, diving
0
1
13
Great work by our outstanding cardiology team using Epic Cosmos data! 📊 @HeyEpic @UCSDCardiology
New in JACC: Advances: Lp(a) testing is still rare nationwide, despite its role in cardiac risk. We analyzed trends using 300M+ patients in Epic Cosmos. ➡️ UCSD’s and University of California’s 1st Cosmos paper ➡️ BEACON’s 1st study 🚀 Press release 👉
0
3
8
New publication from @EKDuranMD @JAHA_AHA: @ucsdhealth @UCSDHealthSci @UCSDCardFellows
@UCSDCardFellows
https://t.co/fBDsf9GYh0
ahajournals.org
0
2
2
New publication from Dr. Wettersten: Kidney Tubular Biomarkers Predict Risk of Death and Heart Failure Readmission in Acute Heart Failure @ucsdhealth @UCSDHealthSci @UCSDCardFellows @UCSDCardFellows
https://t.co/6UumJRWEtD
ahajournals.org
0
0
1
This is the first published study from UC San Diego BEACON. To find out more about the work being done, visit
A new study just published highlights the increasing but low rates of testing for lipoprotein(a) or Lp(a) in 300 million individuals across the US from 2015-2024 @UCSDHealthSci @UCSDHealth @MattRamsisMD @hsbhatia @PamTaubMD @MWilkinsonMD
https://t.co/IYAUpUmUOZ
0
0
5
RT @MattRamsisMD: New in JACC: Advances: Lp(a) testing is still rare nationwide, despite its role in cardiac risk. We analyzed trends usin…
today.ucsd.edu
Researchers from UC San Diego School of Medicine found that testing for lipoprotein(a) — a genetic risk factor for heart disease — remains uncommon in the United States, despite modest increases over...
0
1
0
Original study: https://t.co/tVx3iDxh7b
@UCSDCardFellows
1
0
0
A new study just published highlights the increasing but low rates of testing for lipoprotein(a) or Lp(a) in 300 million individuals across the US from 2015-2024 @UCSDHealthSci @UCSDHealth @MattRamsisMD @hsbhatia @PamTaubMD @MWilkinsonMD
https://t.co/IYAUpUmUOZ
today.ucsd.edu
Researchers from UC San Diego School of Medicine found that testing for lipoprotein(a) — a genetic risk factor for heart disease — remains uncommon in the United States, despite modest increases over...
1
3
9